Biochemical control of prostate cancer with iodine-125 brachytherapy alone
Clinical and Translational Oncology,  Clinical Article

da Ponte Amadei LP et al. – Low–dose–rate brachytherapy (LDRB) alone should be considered mostly for low–risk patients. PSA level was a strong independent prognostic factor. The authors support the use of the Phoenix criteria for detection of BF in patients submitted to LDRB alone.

  • Data on 220 patients treated between 1998 and 2002 with LDRB were retrospectively analysed.
  • Neoadjuvant hormone therapy was used in 74 (33.6%) patients.

  • Median follow–up was 53.5 months (24–116).
  • Five year BFFS was 83.0% and 83.7% using, respectively, the ASTRO and Phoenix criteria.
  • Low –and intermediate–risk patients presented, respectively, 86.7% and 77.8% 5–year BFFS using the ASTRO definition (p=0.069), and 88.5% and 78.6% considering the Phoenix criteria (p=0.016).
  • Bounce was observed in 66 (30%) patients.
  • Multivariate analysis detected PSA at diagnosis <10 ng/ml and less than 50% positive biopsy fragments as favourable prognostic factors, regarding BF using both criteria.
  • For the Phoenix criteria, also Gleason score <7 and low–risk group were identified as independent favourable prognostic factors.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More